Sensus Healthcare Inc (SRTS) USD0.01

Sell:$7.00Buy:$7.30$0.13 (1.85%)

Prices delayed by at least 15 minutes
Sell:$7.00
Buy:$7.30
Change:$0.13 (1.85%)
Prices delayed by at least 15 minutes
Sell:$7.00
Buy:$7.30
Change:$0.13 (1.85%)
Prices delayed by at least 15 minutes

Company Information

About this company

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.

Key people

Joseph C. Sardano
Chairman of the Board, Chief Executive Officer, Co-Founder
Michael J. Sardano
President, General Counsel, Corporate Secretary, Director
Javier Rampolla
Chief Financial Officer
Magdalena Martinez
Chief Operating Officer
Emiliano Sosa
Chief Technology Officer
Megan Cornish
Non-Employee Independent Director
William McCall
Non-Employee Independent Director
Anthony B. Petrelli
Non-Employee Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US81728J1097
  • Market cap
    $114.57m
  • Employees
    35
  • Shares in issue
    16.93m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.